News
-
-
PRESS RELEASE
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
BioNxt Solutions Inc. launches feasibility study for oral dissolvable film of Semaglutide, a GLP-1 receptor agonist, to improve patient experience and adherence. Study aims to assess compatibility and generate data for formulation optimization and patent strategy -
PRESS RELEASE
Silver Tiger Metals: Mexico's next big silver mine?
Silver Tiger Metals is set to become Mexico's next big silver mine with over $120 million institutional financing and 200 million ounces of silver equivalent. CEO Glenn Jessome explains the key factors for success in the mining sector -
-
-
-
-
-
PRESS RELEASE
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
New peer-reviewed data supports masitinib's potential for treating Alzheimer's disease through cognitive enhancement and neuroprotection. Phase 3 study authorized by FDA and key EU countries -
PRESS RELEASE
AB Science - De nouvelles données évaluées par des pairs apportent des preuves solides du potentiel du masitinib dans le traitement de la maladie d’Alzheimer
Des données évaluées par des pairs confirment l'efficacité potentielle du masitinib dans le traitement de la maladie d'Alzheimer, avec un focus sur l'amélioration cognitive et la neuroprotection
